Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Attal

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Leukemia|January 23, 2009
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemiaN Gallay, C Dos Santos, L Cuzin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphomaC Haioun, E Lepage, C Gisselbrecht, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
Bone Marrow Transplantation|January 1, 1991
Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patientsL Sutton, V Leblond, C Le Maignan, et al.
Bone Marrow Transplantation|June 1, 1995
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Presse Medicale (Paris, France : 1983)|September 3, 1994
[Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse]B Rio, J Y Cahn, M Attal, et al.
Bone Marrow Transplantation|January 1, 1991
Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT GroupJ Reiffers, A M Stoppa, F Rigal-Huguet, et al.
Journal of Clinical Microbiology|August 9, 2003
Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assayC Mengelle, K Sandres-Sauné, C Pasquier, et al.
Blood|June 1, 1992
Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trialM Attal, F Huguet, H Rubie, et al.
European Cytokine Network|March 1, 1991
Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patientsD Blaise, P Viens, D Olive, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Leukemia|January 23, 2009
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemiaN Gallay, C Dos Santos, L Cuzin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphomaC Haioun, E Lepage, C Gisselbrecht, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
Bone Marrow Transplantation|January 1, 1991
Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patientsL Sutton, V Leblond, C Le Maignan, et al.
Bone Marrow Transplantation|June 1, 1995
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Presse Medicale (Paris, France : 1983)|September 3, 1994
[Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse]B Rio, J Y Cahn, M Attal, et al.
Bone Marrow Transplantation|January 1, 1991
Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT GroupJ Reiffers, A M Stoppa, F Rigal-Huguet, et al.
Journal of Clinical Microbiology|August 9, 2003
Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assayC Mengelle, K Sandres-Sauné, C Pasquier, et al.
Blood|June 1, 1992
Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trialM Attal, F Huguet, H Rubie, et al.
European Cytokine Network|March 1, 1991
Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patientsD Blaise, P Viens, D Olive, et al.
Pageof 16